Inadequacy of high-dose fluconazole monotherapy among cerebrospinal fluid cryptococcal antigen (CrAg)–positive human immunodeficiency virus-infected persons …

T Beyene, AG Zewde, A Balcha, B Hirpo… - Clinical Infectious …, 2017 - academic.oup.com
A total of 817 human immunodeficiency virus-infected Ethiopians with CD4< 150 cells/mL
underwent plasma cryptococcal antigen (CRAG) screening. CRAG prevalence was 6.2%. Of …

Inadequacy of High-Dose Fluconazole Monotherapy Among Cerebrospinal Fluid Cryptococcal Antigen (CrAg)–Positive Human Immunodeficiency Virus-Infected …

T Beyene, AG Zewde, A Balcha, B Hirpo… - Clinical Infectious …, 2017 - academic.oup.com
A total of 817 human immunodeficiency virus-infected Ethiopians with CD4< 150 cells/mL
underwent plasma cryptococcal antigen (CRAG) screening. CRAG prevalence was 6.2%. Of …

Inadequacy of High-Dose Fluconazole Monotherapy Among Cerebrospinal Fluid Cryptococcal Antigen (CrAg)-Positive Human Immunodeficiency Virus-Infected …

T Beyene, AG Zewde, A Balcha, B Hirpo… - … Diseases: an Official …, 2017 - europepmc.org
A total of 817 human immunodeficiency virus-infected Ethiopians with CD4< 150 cells/mL
underwent plasma cryptococcal antigen (CRAG) screening. CRAG prevalence was 6.2%. Of …

Inadequacy of High-Dose Fluconazole Monotherapy Among Cerebrospinal Fluid Cryptococcal Antigen (CrAg)-Positive Human Immunodeficiency Virus-Infected …

T Beyene, AG Zewde, A Balcha… - … publication of the …, 2017 - pubmed.ncbi.nlm.nih.gov
A total of 817 human immunodeficiency virus-infected Ethiopians with CD4< 150 cells/mL
underwent plasma cryptococcal antigen (CRAG) screening. CRAG prevalence was 6.2%. Of …

Inadequacy of High-Dose Fluconazole Monotherapy among Cerebrospinal Fluid Cryptococcal Antigen (CrAg)-Positive Human Immunodeficiency Virus-Infected …

T Beyene, AG Zewde, A Balcha, B Hirpo… - Clinical Infectious …, 2017 - experts.umn.edu
A total of 817 human immunodeficiency virus-infected Ethiopians with CD4< 150 cells/mL
underwent plasma cryptococcal antigen (CRAG) screening. CRAG prevalence was 6.2%. Of …

Inadequacy of High-Dose Fluconazole Monotherapy Among Cerebrospinal Fluid Cryptococcal Antigen (CrAg)–Positive Human Immunodeficiency Virus-Infected …

T Beyene, AG Zewde, A Balcha, B Hirpo… - Clinical Infectious …, 2017 - JSTOR
A total of 817 human immunodeficiency virus-infected Ethiopians with CD4< 150 cells/mL
underwent plasma cryptococcal antigen (CRAG) screening. CRAG prevalence was 6.2%. Of …

Inadequacy of High-Dose Fluconazole Monotherapy Among Cerebrospinal Fluid Cryptococcal Antigen (CrAg)-Positive Human Immunodeficiency Virus-Infected …

T Beyene, AG Zewde, A Balcha… - Clinical Infectious …, 2017 - search.ebscohost.com
A total of 817 human immunodeficiency virus-infected Ethiopians with CD4 &lt; 150 cells/mL
underwent plasma cryptococcal antigen (CRAG) screening. CRAG prevalence was 6.2%. Of …

[HTML][HTML] Inadequacy of High-Dose Fluconazole Monotherapy Among Cerebrospinal Fluid Cryptococcal Antigen (CrAg)–Positive Human Immunodeficiency Virus …

T Beyene, AG Zewde, A Balcha, B Hirpo… - … Diseases: An Official …, 2017 - ncbi.nlm.nih.gov
A total of 817 human immunodeficiency virus-infected Ethiopians with CD4< 150 cells/mL
underwent plasma cryptococcal antigen (CRAG) screening. CRAG prevalence was 6.2%. Of …

Inadequacy of High-Dose Fluconazole Monotherapy Among Cerebrospinal Fluid Cryptococcal Antigen (CrAg)-Positive Human Immunodeficiency Virus-Infected …

T Beyene, AG Zewde, A Balcha, B Hirpo… - … Diseases: an Official …, 2017 - europepmc.org
A total of 817 human immunodeficiency virus-infected Ethiopians with CD4< 150 cells/mL
underwent plasma cryptococcal antigen (CRAG) screening. CRAG prevalence was 6.2%. Of …